However, there is now compelling evidence that it is the recruitment of specific lymphocyte subsets that are crucial in driving anti-tumour responses, in particular CD8+ T cells, where the ability to control HPV-positive tumours is likely mediated by CD8+ T cell-specific recognition of HPV-derived antigens [38, 39]. The gene discussed is CD8A; the disease is neoplasm.